{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:49:34Z","timestamp":1786373374241,"version":"build-2736575974"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.2215\/cjn.08340814","type":"journal-article","created":{"date-parts":[[2015,4,17]],"date-time":"2015-04-17T21:42:51Z","timestamp":1429306971000},"page":"784-790","source":"Crossref","is-referenced-by-count":21,"title":["Hemostatic Factors, APOL1 Risk Variants, and the Risk of ESRD in the Atherosclerosis Risk in Communities Study"],"prefix":"10.2215","volume":"10","author":[{"given":"Adrienne","family":"Tin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan E.","family":"Grams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisa M.","family":"Maruthur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad C.","family":"Astor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Couper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas H.","family":"Mosley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Fornage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rulan S.","family":"Parekh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Coresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen Hong Linda","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-10-20230601","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1053\/j.ajkd.2008.10.044","article-title":"Inflammation, hemostasis, and the risk of kidney function decline in the Atherosclerosis Risk in Communities (ARIC) Study.","volume":"53","author":"Bash","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"R3-10-20230601","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1097\/01.ASN.0000146422.45434.35","article-title":"Inflammatory and prothrombotic markers and the progression of renal disease in elderly individuals.","volume":"15","author":"Fried","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R4-10-20230601","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1053\/j.ajkd.2009.01.001","article-title":"Does inflammation fuel the fire in CKD?","volume":"53","author":"Rifkin","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"R5-10-20230601","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1053\/j.ajkd.2012.02.335","article-title":"Inflammation and coagulation markers and kidney function decline: the Multi-Ethnic Study of Atherosclerosis (MESA).","volume":"60","author":"Hiramoto","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"R6-10-20230601","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1193032","article-title":"Association of trypanolytic ApoL1 variants with kidney disease in African Americans.","volume":"329","author":"Genovese","year":"2010","journal-title":"Science"},{"key":"R7-10-20230601","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00439-010-0861-0","article-title":"Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene.","volume":"128","author":"Tzur","year":"2010","journal-title":"Hum Genet"},{"key":"R8-10-20230601","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1056\/NEJMoa1310345","article-title":"APOL1 risk variants, race, and progression of chronic kidney disease.","volume":"369","author":"Parsa","year":"2013","journal-title":"N Engl J Med"},{"key":"R9-10-20230601","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1681\/ASN.2013010113","article-title":"APOL1 variants associate with increased risk of CKD among African Americans.","volume":"24","author":"Foster","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"R10-10-20230601","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.2215\/CJN.01330214","article-title":"Gene-gene and gene-environment interactions in apolipoprotein L1 gene-associated nephropathy.","volume":"9","author":"Freedman","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"R11-10-20230601","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1681\/ASN.2011040388","article-title":"APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy.","volume":"22","author":"Kopp","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"R13-10-20230601","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1128\/JVI.02828-13","article-title":"The innate immune factor apolipoprotein L1 restricts HIV-1 infection.","volume":"88","author":"Taylor","year":"2014","journal-title":"J Virol"},{"key":"R14-10-20230601","doi-asserted-by":"crossref","first-page":"F326","DOI":"10.1152\/ajprenal.00647.2013","article-title":"APOL1 risk variants enhance podocyte necrosis through compromising lysosomal membrane permeability.","volume":"307","author":"Lan","year":"2014","journal-title":"Am J Physiol Renal Physiol"},{"key":"R16-10-20230601","doi-asserted-by":"crossref","first-page":"E2130","DOI":"10.1073\/pnas.1400699111","article-title":"Evolution of the primate trypanolytic factor APOL1.","volume":"111","author":"Thomson","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R18-10-20230601","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/1047-2797(92)90096-9","article-title":"The Atherosclerosis Risk in Communities (ARIC) Study. Introduction and objectives of the hemostasis component.","volume":"2","author":"Sharrett","year":"1992","journal-title":"Ann Epidemiol"},{"key":"R19-10-20230601","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1055\/s-0038-1646519","article-title":"ARIC hemostasis study\u2014I. Development of a blood collection and processing system suitable for multicenter hemostatic studies.","volume":"61","author":"Papp","year":"1989","journal-title":"Thromb Haemost"},{"key":"R20-10-20230601","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1055\/s-0038-1647351","article-title":"ARIC hemostasis study\u2014II. Organizational plan and feasibility study.","volume":"64","author":"Wu","year":"1990","journal-title":"Thromb Haemost"},{"key":"R21-10-20230601","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/1047-2797(92)90017-K","article-title":"Short-term intraindividual variability in hemostasis factors. The ARIC Study. Atherosclerosis Risk in Communities Intraindividual Variability Study.","volume":"2","author":"Chambless","year":"1992","journal-title":"Ann Epidemiol"},{"key":"R22-10-20230601","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/nrneph.2013.34","article-title":"APOL1 variants and kidney disease in people of recent African ancestry.","volume":"9","author":"Genovese","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"R23-10-20230601","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1086\/519795","article-title":"PLINK: A tool set for whole-genome association and population-based linkage analyses.","volume":"81","author":"Purcell","year":"2007","journal-title":"Am J Hum Genet"},{"key":"R24-10-20230601","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1093\/hmg\/ddr118","article-title":"The MYH9\/APOL1 region and chronic kidney disease in European-Americans.","volume":"20","author":"O\u2019Seaghdha","year":"2011","journal-title":"Hum Mol Genet"},{"key":"R25-10-20230601","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1681\/ASN.2011050519","article-title":"Population-based risk assessment of APOL1 on renal disease.","volume":"22","author":"Friedman","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"R26-10-20230601","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"R27-10-20230601","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate.","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"R28-10-20230601","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1053\/j.ajkd.2009.12.016","article-title":"Risk implications of the new CKD Epidemiology Collaboration (CKD-EPI) equation compared with the MDRD Study equation for estimated GFR: The Atherosclerosis Risk in Communities (ARIC) Study.","volume":"55","author":"Matsushita","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"R30-10-20230601","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1001\/jama.2011.451","article-title":"A predictive model for progression of chronic kidney disease to kidney failure.","volume":"305","author":"Tangri","year":"2011","journal-title":"JAMA"},{"key":"R31-10-20230601","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1172\/JCI109521","article-title":"Human plasma protein C: isolation, characterization, and mechanism of activation by alpha-thrombin.","volume":"64","author":"Kisiel","year":"1979","journal-title":"J Clin Invest"},{"key":"R32-10-20230601","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0268-960X(03)00025-0","article-title":"Activation of factor VIII and mechanisms of cofactor action.","volume":"18","author":"Fay","year":"2004","journal-title":"Blood Rev"},{"key":"R33-10-20230601","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1749-6632.1981.tb29743.x","article-title":"Human protein C: inactivation of factors V and VIII in plasma by the activated molecule.","volume":"370","author":"Marlar","year":"1981","journal-title":"Ann N Y Acad Sci"},{"key":"R34-10-20230601","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1161\/01.CIR.0000131660.51520.9A","article-title":"Bidirectional relation between inflammation and coagulation.","volume":"109","author":"Levi","year":"2004","journal-title":"Circulation"},{"key":"R35-10-20230601","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1681\/ASN.2011010069","article-title":"APOL1 localization in normal kidney and nondiabetic kidney disease.","volume":"22","author":"Madhavan","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"R36-10-20230601","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1681\/ASN.2013070700","article-title":"Plasma apolipoprotein L1 levels do not correlate with CKD.","volume":"25","author":"Bruggeman","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"R37-10-20230601","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1161\/01.ATV.0000017470.08363.AB","article-title":"Protein C, antithrombin, and venous thromboembolism incidence: A prospective population-based study.","volume":"22","author":"Folsom","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R38-10-20230601","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ijcard.2010.09.051","article-title":"Hemostatic markers are associated with the risk and prognosis of atrial fibrillation: The ARIC study.","volume":"155","author":"Alonso","year":"2012","journal-title":"Int J Cardiol"},{"key":"R39-10-20230601","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1111\/j.1538-7836.2009.03577.x","article-title":"Low protein C and incidence of ischemic stroke and coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) Study.","volume":"7","author":"Folsom","year":"2009","journal-title":"J Thromb Haemost"},{"key":"R40-10-20230601","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1097\/00004872-199816070-00004","article-title":"Hemostasis in normotensive and hypertensive men: Results of the PROCAM study. The prospective cardiovascular M\u00fcnster study.","volume":"16","author":"Junker","year":"1998","journal-title":"J Hypertens"},{"key":"R41-10-20230601","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1055\/s-0038-1642506","article-title":"Haemostatic abnormalities persist despite glycaemic improvement by insulin therapy in lean type 2 diabetic patients.","volume":"71","author":"Kn\u00f6bl","year":"1994","journal-title":"Thromb Haemost"},{"key":"R42-10-20230601","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1055\/s-0038-1661192","article-title":"Protein C antigen is not an acute phase reactant and is often high in ischemic heart disease and diabetes.","volume":"52","author":"Vigan\u00f2","year":"1984","journal-title":"Thromb Haemost"},{"key":"R43-10-20230601","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1007\/s001250050598","article-title":"Protein C activation in NIDDM patients.","volume":"39","author":"Gabazza","year":"1996","journal-title":"Diabetologia"},{"key":"R44-10-20230601","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0049-3848(89)90088-1","article-title":"Protein C assays in uremia.","volume":"54","author":"S\u00f8rensen","year":"1989","journal-title":"Thromb Res"},{"key":"R45-10-20230601","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-2141.2005.05753.x","article-title":"The interactions between inflammation and coagulation.","volume":"131","author":"Esmon","year":"2005","journal-title":"Br J Haematol"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201505000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:45:22Z","timestamp":1786369522000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201505000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.08340814","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]}}}